Approximately 90% of Grade 1 meningiomas were allocated to the MC ‘benign’ and the remaining 10% to the MC ‘intermediate’ or, in a single case, to the class of SMARCE1‐altered. The gene discussed is SMARCE1; the disease is meningioma.